Correction: Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody

Correction: Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody

Saved in:

Bibliographic Details
Main Authors:	Isabella Hrabal, Elmira Aliabadi, Sven Reiche, Saskia Weber, Cora M. Holicki, Laura Schmid, Christine Fast, Charlotte Schröder, Benjamin Gutjahr, Patrick Behrendt, Martin H. Groschup, Martin Eiden
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-05-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-025-01512-2
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody
by: Isabella Hrabal, et al.
Published: (2025-03-01)

Tracking WNV transmission with a combined dog and wild boar surveillance system
by: Cora M. Holicki, et al.
Published: (2025-04-01)

Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus
by: Fan Yang, et al.
Published: (2020-01-01)

Experience in the use of neutralizing monoclonal antibodies in kidney transplant recipients with COVID-19
by: I. G. Kim, et al.
Published: (2023-04-01)

Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV – a review
by: Sharana Mahomed, et al.
Published: (2025-04-01)

Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana
by: Nuttapat Pisuttinusart, et al.
Published: (2024-12-01)

Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2
by: Qian Wang, et al.
Published: (2025-07-01)

Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders
by: Stephanie Maciuba, et al.
Published: (2023-12-01)

Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies
by: Ignacio Melero, et al.
Published: (2023-10-01)

Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus
by: Yanfang Zhang, et al.
Published: (2025-01-01)

Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies.
by: Bongiwe Ndlovu, et al.
Published: (2025-06-01)

Computational prediction of neutralization epitopes targeted by human anti-V3 HIV monoclonal antibodies.
by: Evgeny Shmelkov, et al.
Published: (2014-01-01)

Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody.
by: Xiaohua Ye, et al.
Published: (2016-03-01)

Experimental study of the pharmacokinetics of monoclonal antibodies to α4β1-integrin in guinea pigs
by: B. N. Krapivin, et al.
Published: (2018-02-01)

False Memories of Emotional and Neutral Words
by: Jennifer El Sharkawy, et al.
Published: (2008-01-01)

Cross-neutralization ability of anti-MERS-CoV monoclonal antibodies against a variety of merbecoviruses
by: Lin Pan, et al.
Published: (2025-07-01)

Un giorno feriale (traduzione di Elena Zuccolo)
by: Bohumil Hrabal
Published: (2019-12-01)

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.
by: Elizabeth S Munroe, et al.
Published: (2025-01-01)

Neutralizing monoclonal antibodies improve biodistribution of intravenously administered oncolytic adenovirus in human CD46-transgenic mice.
by: Masahisa Hemmi, et al.
Published: (2025-01-01)

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment
by: Elizabeth S. Munroe, et al.
Published: (2025-01-01)

Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews
by: Xinglong Liu, et al.
Published: (2024-12-01)

Lessons learned and real-world insights from implementing neutralizing monoclonal antibody programs for treatment of COVID-19
by: Nalini Ambrose, et al.
Published: (2024-01-01)

A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B
by: Hongyin Fan, et al.
Published: (2024-12-01)

A human monoclonal antibody isolated from Japanese encephalitis virus vaccine-vaccinated volunteer neutralizing various flaviviruses
by: Dong Chen, et al.
Published: (2024-12-01)

Development and evaluation of a recombinant monoclonal human antibody with virus-neutralizing activity against the F glycoprotein of respiratory syncytial virus
by: Sergey A. Klotchenko, et al.
Published: (2024-12-01)

Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals.
by: Davide Corti, et al.
Published: (2010-01-01)

Ion cyclotron waves: a tool for characterizing neutral particle profiles in extended exospheres
by: Helmut Lammer, et al.
Published: (2025-07-01)

Isolation and Characterization of E8 Monoclonal Antibodies from Donors Vaccinated with Recombinant Vaccinia Vaccine with Efficient Neutralization of Authentic Monkeypox Virus
by: Yutao Shi, et al.
Published: (2025-04-01)

A novel neutralizing monoclonal antibody recognizes a linear antigenic epitope of the spike protein of swine acute diarrhoea syndrome coronavirus
by: Lin Zhang, et al.
Published: (2024-11-01)

Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment.
by: Lindsey E Fish, et al.
Published: (2025-01-01)

Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment
by: Lindsey E. Fish, et al.
Published: (2025-01-01)

Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.
by: Zhen-yong Keck, et al.
Published: (2012-01-01)

Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitors
by: Carly R. Cabel, et al.
Published: (2025-05-01)

Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants
by: Frédéric Coutant, et al.
Published: (2024-12-01)

Durable and Cost-Effective Neutral Density Filters Utilizing Multiple Reflections in Glass Slide Stacks
by: Krzysztof M. Czajkowski, et al.
Published: (2017-01-01)

Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model.
by: Xiaodong Xiao, et al.
Published: (2010-10-01)

Correlation Between the Anticorrosive Performance of Protective Coatings Under Neutral Salt Spray Testing and Outdoor Atmospheric and Immersion Exposure
by: Matthias J. Schmid
Published: (2024-10-01)

Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex
by: Minoru Tada, et al.
Published: (2023-12-01)

Use of a synthetic biosensor for neutralizing activity-biased selection of monoclonal antibodies against atroxlysin-I, an hemorrhagic metalloproteinase from Bothrops atrox snake venom.
by: Francisco Santos Schneider, et al.
Published: (2014-04-01)

Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination
by: Yuxin Chen, et al.
Published: (2021-01-01)